First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment ...

Avery Dennison is set to announce its fourth-quarter results soon, with analysts projecting single-digit growth in its bottom ...

Palm Valley Capital Fund analyzes market disparities and small cap value opportunities amid persistent inflation. Review our ...

There are those in our team who believe that the strategy must be to go deep and long on gold and copper in 2026. Any ...